Publication: XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.
Program
Authors
Authors
UYGUN, K
BILICI, A
KAYA, S
Oven, Ustaalioglu
YILDIZ, R
TEMIZ, S
Seker, MESUT
AKSU, G
CABUK, D
GUMUS, M
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Source:
Keywords:
Keywords
Citation
UYGUN K., BILICI A., KAYA S., Oven U., YILDIZ R., TEMIZ S., Seker M., AKSU G., CABUK D., GUMUS M., -XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.-, Asian Pacific journal of cancer prevention : APJCP, cilt.14, ss.2283-8, 2013